Literature DB >> 33892132

Hospitalization-associated muscle weakness and functional outcomes among oldest old patients: A hospital-based cohort study.

Chieh-Han Huang1, Chia-Chia Hsu2, Pei-Chin Yu3, Li-Ning Peng4, Ming-Hsien Lin5, Liang-Kung Chen6.   

Abstract

AIM: To investigate the prognostic significance of hospitalization-associated muscle weakness for short-term and long-term functional declines among oldest old hospitalized patients.
METHODS: We conducted a retrospective cohort study in the Geriatric Evaluation and Management Unit (GEMU) of a tertiary medical center in Taiwan. Data from patients admitted to the GEMU were collected, including demographic characteristics, underlying diseases, functional assessments, and nutritional status. Handgrip strength was measured at admission and before discharge, and hospitalization-associated muscle weakness was defined accordingly. Functional status was ascertained by a telephone survey, and functional decline was defined based on a comparison with each patient's functional status before discharge.
RESULTS: Overall, data from 555 patients were retrieved, and 431 patients (mean age: 86.0 ± 6.2 years, 78.5% males) were included in the study, with a mean Barthel Index score of 74.7 ± 20.8, Mini-Mental State Examination (MMSE) score of 19.1 ± 6.8, Geriatric Depression Scale (GDS-5) score of 2.2 ± 1.6, Mini-Nutritional Assessment-Short Form (MNA-SF) score of 8.9 ± 3.0, Cumulative Illness Rating Scale-Geriatric (CIRS-G) score of 2.2 ± 0.9, and the regular use of 6.7 ± 3.5 medications. Patients with a 1-month postdischarge functional decline had significantly lower body weight and body mass index, more severe frailty and more hospitalization-associated muscle weakness. Patients with a 6-month postdischarge functional decline had lower body weight, BMI, MMSE scores, MNA-SF scores, handgrip strength, Barthel Index scores, and Braden Scale scores. BMI (OR: 0.815, 95% CI: 0.691-0.962, P = 0.015) and hospitalization-associated muscle weakness (OR: 1.227, 95% CI: 1.147-1.332, P < 0.001) were significantly associated with a 1-month postdischarge functional decline. Hospitalization-associated muscle weakness (OR: 1.067, 95% CI: 1.035-1.101, P < 0.001), the risk of pressure sores (Braden Scale, OR: 0.767, 95% CI: 0.646-0.910, P = 0.002), and BMI (OR: 0.914, 95% CI: 0.838-0.998, P = 0.045) were independently associated with a 6-month postdischarge functional decline.
CONCLUSIONS: Hospitalization-associated muscle weakness significantly predicts functional decline among oldest old patients hospitalized for acute conditions. Further interventional studies are needed to examine the causal relationship between hospitalization-associated muscle weakness and clinical outcomes.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Disability; Handgrip strength; Muscle weakness; Sarcopenia

Year:  2021        PMID: 33892132     DOI: 10.1016/j.exger.2021.111353

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  3 in total

1.  Association between changes in frailty during hospitalization in older adults and 3-month mortality after discharge.

Authors:  Hiroyuki Umegaki; Masaaki Nagae; Hitoshi Komiya; Kazuhisa Watanabe; Yosuke Yamada; Tomomichi Sakai
Journal:  Eur Geriatr Med       Date:  2022-10-19       Impact factor: 3.269

2.  Handheld dynamometer reliability to measure knee extension strength in rehabilitation patients-A cross-sectional study.

Authors:  João Pinto-Ramos; Tiago Moreira; Frederico Costa; Helena Tavares; João Cabral; Cristina Costa-Santos; Joana Barroso; Bernardo Sousa-Pinto
Journal:  PLoS One       Date:  2022-05-17       Impact factor: 3.240

3.  Changes in Physical Functioning and Fall-Related Factors in Older Adults Due to COVID-19 Social Isolation.

Authors:  Fernando Damasceno de Albuquerque Angelo; Fabiano de Souza Fonseca; Breno Quintella Farah; Rodrigo Cappato de Araújo; Bruno Remígio Cavalcante; Natália Barros Beltrão; André Luiz Torres Pirauá
Journal:  Can Geriatr J       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.